Cargando…
PNU282987 inhibits amyloid-β aggregation by upregulating astrocytic endogenous αB-crystallin and HSP-70 via regulation of the α7AChR, PI3K/Akt/HSF-1 signaling axis
Alzheimer's disease (AD) is a chronic and irreversible neurodegenerative disorder. Abnormal aggregation of the neurotoxic amyloid-β (Aβ) peptide is an early event in AD. The activation of astrocytic α7 nicotinic acetylcholine receptor (α7 nAChR) can inhibit Aβ aggregation; thus, the molecular m...
Autores principales: | Ren, Zhenkui, Dong, Zhihui, Xie, Peng, Lv, Ju, Hu, Yumei, Guan, Zhizhong, Zhang, Chunlin, Yu, Wenfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248489/ https://www.ncbi.nlm.nih.gov/pubmed/32377707 http://dx.doi.org/10.3892/mmr.2020.11132 |
Ejemplares similares
-
Combined administration of SHP2 inhibitor SHP099 and the α7nAChR agonist PNU282987 protect mice against DSS-induced colitis
por: Xiao, Junhua, et al.
Publicado: (2020) -
α7 Nicotinic Acetylcholine Receptor Agonist PNU-282987 Ameliorates Cognitive Impairment Induced by Chronic Intermittent Hypoxia
por: Shen, Hui, et al.
Publicado: (2021) -
Activation of α7 nAChR by PNU-282987 improves synaptic and cognitive functions through restoring the expression of synaptic-associated proteins and the CaM-CaMKII-CREB signaling pathway
por: Wang, Xiao-Ling, et al.
Publicado: (2020) -
A Selective α7 Nicotinic Acetylcholine Receptor Agonist, PNU-282987, Attenuates ILC2s Activation and Alternaria-Induced Airway Inflammation
por: Yuan, Fang, et al.
Publicado: (2021) -
Effect of Intrahippocampal Administration of α7 Subtype Nicotinic Receptor Agonist PNU-282987 and Its Solvent Dimethyl Sulfoxide on the Efficiency of Hypoxic Preconditioning in Rats
por: Zakharova, Elena I., et al.
Publicado: (2021)